Menyhárt O et al.: Molecular markers and potential therapeutic targets in non-WNT / non-SHH (Group 3 and Group 4) medulloblastomas, J Hematol Oncol (2019)

Fernando TM, Győrffy B, et al.: BCL6 evolved to enable stress tolerance in vertebrates and is broadly required by cancer cells to adapt to stress. Cancer Discovery (2019)

We have released a new analysis platform to validate predictive biomarkers in breast cancer - click on image to visit site.

Menyhárt O et al.: Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer. Front Pharmacol. (2019)

Munkácsy G et al. Induced overexpression efficiency across 342 independent experiments shows a success rate of 39% Scienfic Reports (2019)

Menyhárt O et al.: Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci. (2018)

Győrffy B et al. : Factors influencing the scientific performance of Momentum grant holders: An evaluation of the first 117 research groups, Scientometrics (2018)

Patten DK, Corleone G, Győrffy B, Pongor LS, Magnani L et al. Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer, Nature Medicine (2018)

Nagy Á et al. : Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets, Scientific Reports (2018)

Győrffy B et al.: An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes, British Journal of Cancer (2018)